Columbus Macro LLC Acquires 6,510 Shares of Cardinal Health, Inc. (NYSE:CAH)

Columbus Macro LLC lifted its stake in Cardinal Health, Inc. (NYSE:CAH - Free Report) by 55.1% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 18,319 shares of the company's stock after purchasing an additional 6,510 shares during the period. Columbus Macro LLC's holdings in Cardinal Health were worth $2,167,000 at the end of the most recent quarter.

Several other large investors have also recently bought and sold shares of CAH. Paragon Capital Management Inc. increased its position in Cardinal Health by 0.7% in the third quarter. Paragon Capital Management Inc. now owns 14,857 shares of the company's stock worth $1,642,000 after purchasing an additional 99 shares during the period. Huntington National Bank raised its stake in shares of Cardinal Health by 0.9% during the third quarter. Huntington National Bank now owns 10,792 shares of the company's stock worth $1,193,000 after buying an additional 100 shares during the last quarter. Frazier Financial Advisors LLC lifted its holdings in Cardinal Health by 69.8% in the third quarter. Frazier Financial Advisors LLC now owns 253 shares of the company's stock valued at $28,000 after buying an additional 104 shares during the period. UMB Bank n.a. grew its holdings in Cardinal Health by 4.9% during the 3rd quarter. UMB Bank n.a. now owns 2,249 shares of the company's stock worth $249,000 after acquiring an additional 106 shares during the period. Finally, Raleigh Capital Management Inc. raised its position in shares of Cardinal Health by 29.6% during the 4th quarter. Raleigh Capital Management Inc. now owns 464 shares of the company's stock valued at $55,000 after acquiring an additional 106 shares during the last quarter. Institutional investors and hedge funds own 87.17% of the company's stock.

Cardinal Health Price Performance

NYSE:CAH traded up $0.57 on Friday, hitting $127.62. 1,797,495 shares of the company's stock were exchanged, compared to its average volume of 2,399,000. The firm has a 50-day moving average price of $122.46 and a 200-day moving average price of $115.14. Cardinal Health, Inc. has a 52 week low of $93.17 and a 52 week high of $132.84. The company has a market cap of $30.83 billion, a P/E ratio of 23.81, a price-to-earnings-growth ratio of 1.46 and a beta of 0.63.

Cardinal Health (NYSE:CAH - Get Free Report) last released its earnings results on Thursday, January 30th. The company reported $1.93 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.74 by $0.19. Cardinal Health had a negative return on equity of 59.57% and a net margin of 0.59%. On average, research analysts expect that Cardinal Health, Inc. will post 7.92 earnings per share for the current fiscal year.

Cardinal Health Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, April 15th. Investors of record on Tuesday, April 1st will be paid a $0.5056 dividend. The ex-dividend date is Tuesday, April 1st. This represents a $2.02 annualized dividend and a dividend yield of 1.58%. Cardinal Health's dividend payout ratio is presently 37.69%.

Analyst Upgrades and Downgrades

A number of equities research analysts recently commented on CAH shares. TD Cowen raised Cardinal Health from a "hold" rating to a "buy" rating and lifted their price objective for the stock from $130.00 to $144.00 in a research note on Wednesday, January 8th. UBS Group boosted their price objective on shares of Cardinal Health from $134.00 to $139.00 and gave the company a "buy" rating in a report on Monday, November 4th. Evercore ISI raised shares of Cardinal Health from an "in-line" rating to an "outperform" rating and set a $140.00 price target for the company in a report on Tuesday, January 7th. Deutsche Bank Aktiengesellschaft raised their price objective on Cardinal Health from $119.00 to $124.00 and gave the stock a "hold" rating in a research note on Monday, November 4th. Finally, Wells Fargo & Company increased their price target on Cardinal Health from $135.00 to $136.00 and gave the stock an "equal weight" rating in a report on Tuesday. Four analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $136.87.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.